Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 26, 2014
- Revision received May 23, 2014
- Accepted May 26, 2014
- Published online June 30, 2014.
Copyright & Usage
Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved
Author Information
- CHARLOTTE BENSON1⇑,
- JOANNA VITFELL-RASMUSSEN2,
- MARCO MARUZZO1,
- CYRIL FISHER3,
- NINA TUNARIU4,
- SCOTT MITCHELL1,
- OMAR AL-MUDERIS1,
- KHIN THWAY3,
- JAMES LARKIN5 and
- IAN JUDSON1
- 1Sarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK
- 2Oncology Department, Herlev Hospital, Herlev, Denmark
- 3Pathology Department, The Royal Marsden NHS Foundation Trust, London, UK
- 4Radiology Department, The Royal Marsden NHS Foundation Trust, London, UK
- 5Renal and Melanoma Unit, The Royal Marsden NHS Foundation Trust, London, UK
- Correspondence to: Dr. Charlotte Benson, Sarcoma Unit, The Royal Marsden NHS Foundation Trust, Fulham Road, London, SW3 6JJ U.K. Tel: +44 02078082200, Fax +44 02078082113, e-mail: Charlotte.Benson{at}rmh.nhs.uk
In this issue
Jump to section
Related Articles
Cited By...
- Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas)
- 2018 ESMO Sarcoma and GIST Symposium: 'take-home messages in soft tissue sarcoma
- Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature
- Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
- Perivascular epithelioid tumours (PEComas) of the gynaecological tract